nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Clenbuterol—NGF—Parkinson's disease	0.0415	0.459	CrCbGaD
Bupranolol—Clenbuterol—TNF—Parkinson's disease	0.00804	0.089	CrCbGaD
Bupranolol—Bopindolol—HTR1A—Parkinson's disease	0.00719	0.0796	CrCbGaD
Bupranolol—Penbutolol—HTR1A—Parkinson's disease	0.00686	0.0759	CrCbGaD
Bupranolol—Timolol—CYP2D6—Parkinson's disease	0.00593	0.0657	CrCbGaD
Bupranolol—Carteolol—CYP2D6—Parkinson's disease	0.00529	0.0586	CrCbGaD
Bupranolol—Pindolol—HTR1A—Parkinson's disease	0.00494	0.0547	CrCbGaD
Bupranolol—Timolol—ABCB1—Parkinson's disease	0.00424	0.0469	CrCbGaD
Bupranolol—Nadolol—ABCB1—Parkinson's disease	0.00337	0.0373	CrCbGaD
Bupranolol—Pindolol—CYP2D6—Parkinson's disease	0.00296	0.0328	CrCbGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00195	0.00214	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00193	0.00212	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00193	0.00212	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—PDYN—Parkinson's disease	0.0019	0.00209	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—GRM4—Parkinson's disease	0.00189	0.00208	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00188	0.00207	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00187	0.00205	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—PDYN—Parkinson's disease	0.00186	0.00204	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD2—Parkinson's disease	0.00186	0.00204	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR7—Parkinson's disease	0.00186	0.00204	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00183	0.00201	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00182	0.002	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PDYN—Parkinson's disease	0.00181	0.00199	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PENK—Parkinson's disease	0.00179	0.00197	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00178	0.00196	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—GRM5—Parkinson's disease	0.00176	0.00194	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—GRM5—Parkinson's disease	0.00173	0.0019	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00171	0.00188	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00171	0.00188	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00169	0.00186	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00169	0.00186	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00168	0.00185	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—GRM5—Parkinson's disease	0.00168	0.00185	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00167	0.00184	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00165	0.00182	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GPR37—Parkinson's disease	0.00165	0.00182	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00165	0.00181	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00165	0.00181	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00165	0.00181	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00165	0.00181	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GPR37—Parkinson's disease	0.00164	0.00181	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DGKQ—Parkinson's disease	0.00164	0.00181	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PDYN—Parkinson's disease	0.00164	0.0018	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.00162	0.00178	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00162	0.00178	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00161	0.00178	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.0016	0.00176	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00156	0.00172	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—GRM5—Parkinson's disease	0.00153	0.00168	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00151	0.00166	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.0015	0.00165	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.0015	0.00165	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—EDN1—Parkinson's disease	0.00149	0.00163	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00148	0.00163	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00147	0.00161	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00145	0.00159	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00145	0.00159	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00143	0.00157	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00141	0.00155	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00141	0.00155	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00138	0.00152	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00135	0.00148	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RIT2—Parkinson's disease	0.00131	0.00145	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.0013	0.00143	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2A—Parkinson's disease	0.0013	0.00143	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.0013	0.00143	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.00128	0.00141	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.00127	0.0014	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.00126	0.00138	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.00125	0.00138	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.00125	0.00138	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GRK5—Parkinson's disease	0.00125	0.00137	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00124	0.00136	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00124	0.00136	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.00123	0.00135	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.00123	0.00135	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—TAC1—Parkinson's disease	0.00122	0.00134	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.00122	0.00134	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00121	0.00133	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD1—Parkinson's disease	0.0012	0.00132	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.00119	0.00131	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00118	0.0013	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.00118	0.0013	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.00117	0.00129	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD3—Parkinson's disease	0.00116	0.00127	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00116	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00116	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.00115	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.00115	0.00126	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00113	0.00124	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR1A—Parkinson's disease	0.00113	0.00124	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.00112	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GRM4—Parkinson's disease	0.00112	0.00123	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TAC1—Parkinson's disease	0.00111	0.00122	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.0011	0.00121	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.0011	0.00121	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.0011	0.00121	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD1—Parkinson's disease	0.00109	0.00119	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00108	0.00119	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.00108	0.00118	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.00108	0.00118	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00107	0.00118	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.00106	0.00117	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PENK—Parkinson's disease	0.00106	0.00117	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAG—Parkinson's disease	0.00106	0.00117	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD3—Parkinson's disease	0.00105	0.00116	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00105	0.00115	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR7—Parkinson's disease	0.00105	0.00115	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD2—Parkinson's disease	0.00105	0.00115	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.00104	0.00115	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00101	0.00111	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000997	0.0011	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000991	0.00109	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000983	0.00108	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000976	0.00107	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000976	0.00107	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000975	0.00107	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000974	0.00107	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PDYN—Parkinson's disease	0.000969	0.00107	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.000955	0.00105	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.000955	0.00105	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.000953	0.00105	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD2—Parkinson's disease	0.000952	0.00105	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR7—Parkinson's disease	0.000952	0.00105	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GFAP—Parkinson's disease	0.000911	0.001	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000905	0.000995	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GRM5—Parkinson's disease	0.000901	0.000991	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000893	0.000981	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000886	0.000974	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.000882	0.000969	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000873	0.00096	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000862	0.000948	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000848	0.000932	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000839	0.000923	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000829	0.000912	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF20—Parkinson's disease	0.00079	0.000869	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	0.00078	0.000858	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000771	0.000848	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00077	0.000846	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000766	0.000842	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	0.000763	0.000839	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EDN1—Parkinson's disease	0.000762	0.000838	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000754	0.000829	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000753	0.000828	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	0.00074	0.000813	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000736	0.000809	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000734	0.000807	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000724	0.000796	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	0.000724	0.000796	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00072	0.000791	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00071	0.000781	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000709	0.000779	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—INSR—Parkinson's disease	0.000707	0.000777	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000695	0.000764	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000688	0.000756	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000673	0.00074	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGB—Parkinson's disease	0.000668	0.000735	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000668	0.000734	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000667	0.000733	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1A—Parkinson's disease	0.000665	0.000731	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	0.000664	0.000729	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	0.000658	0.000723	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TAC1—Parkinson's disease	0.000655	0.00072	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000653	0.000718	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	0.000649	0.000714	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	0.000645	0.000709	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	0.000644	0.000707	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000643	0.000706	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD1—Parkinson's disease	0.000642	0.000706	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	0.000631	0.000694	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	0.000629	0.000692	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	0.000629	0.000692	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000629	0.000691	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	0.000625	0.000687	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000622	0.000684	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000622	0.000684	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD3—Parkinson's disease	0.000622	0.000684	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	0.000615	0.000676	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	0.000615	0.000676	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	0.000611	0.000672	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000609	0.000669	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000609	0.000669	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000583	0.000641	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000581	0.000638	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	0.000575	0.000632	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000571	0.000627	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	0.000565	0.000621	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	0.000565	0.000621	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	0.000563	0.000619	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR7—Parkinson's disease	0.000562	0.000618	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD2—Parkinson's disease	0.000562	0.000618	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	0.000553	0.000608	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	0.000553	0.000608	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	0.000541	0.000595	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	0.000535	0.000588	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	0.000529	0.000582	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	0.000523	0.000575	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000498	0.000548	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000487	0.000536	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF2—Parkinson's disease	0.000471	0.000518	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	0.000469	0.000516	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	0.000459	0.000504	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1R—Parkinson's disease	0.000456	0.000501	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000455	0.0005	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	0.000452	0.000497	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EDN1—Parkinson's disease	0.00045	0.000495	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000445	0.000489	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	0.000443	0.000486	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000436	0.000479	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000426	0.000469	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	0.00042	0.000461	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NGF—Parkinson's disease	0.000414	0.000455	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	0.000411	0.000451	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	0.000397	0.000436	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000396	0.000435	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	0.000395	0.000434	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—Parkinson's disease	0.000394	0.000433	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	0.000389	0.000427	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	0.000388	0.000427	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000387	0.000426	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	0.000386	0.000424	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	0.000381	0.000419	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	0.00038	0.000418	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	0.000373	0.00041	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	0.000369	0.000406	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOE—Parkinson's disease	0.000366	0.000403	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	0.000361	0.000397	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000345	0.000379	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000337	0.000371	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	0.000334	0.000367	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	0.000334	0.000367	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	0.000327	0.000359	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	0.000327	0.000359	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—INS—Parkinson's disease	0.000313	0.000344	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	0.00028	0.000308	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	0.000274	0.000301	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	0.00027	0.000297	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	0.000267	0.000294	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	0.000265	0.000291	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	0.000261	0.000287	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	0.000246	0.00027	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	0.00024	0.000264	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	0.000234	0.000257	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CASP3—Parkinson's disease	0.000233	0.000256	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—Parkinson's disease	0.000231	0.000254	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	0.000229	0.000251	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	0.000217	0.000239	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK8—Parkinson's disease	0.000214	0.000235	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	0.000213	0.000234	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	0.000186	0.000204	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	0.000182	0.0002	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	0.000138	0.000152	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	0.000137	0.000151	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—Parkinson's disease	0.000137	0.00015	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	0.000135	0.000149	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	0.000134	0.000148	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	0.000127	0.00014	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	0.000124	0.000137	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	8.11e-05	8.92e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	7.94e-05	8.72e-05	CbGpPWpGaD
